Leading with the LNA

Why Santaris opted for an acquisition by Roche over JOBS Act IPO

Given a choice between an acquisition and taking a chance on an IPO, investors in Santaris Pharma A/S took the path of certainty offered by partner Roche (SIX:ROG; OTCQX:RHHBY). They will net a greater than 2x return based on the upfront payment alone.

Last week, the

Read the full 459 word article

How to gain access

Continue reading with a
two-week free trial.